Neutralising antibodies can be marker of COVID-19 vaccine efficacy

A new research shows that even a small quantity of the neutralising antibodies indicates a strong efficacy of the vaccine

In India, pseudo-nationalism trumps science in vaccine clearance

The recent regulatory clearance given to an indigenous developed vaccine candidate in India is an example of vaccine nationalism at its worst and jettisoning of all the principles of an evidence-based, scientific approach

COVID-19 vaccines: Differences, costs, and challenges

The COVID-19 pandemic saw the fastest development of a vaccine ever, with a number of research collaborations making this feat possible. But many challenges also remain

Vaccine rollout battle: First past the post may win major market share

India’s mass vaccination plans may fail if it does not hold open discussions on its plans with health professionals and the people

    × To Subscribe